Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells

K Takenaka, TK Prasolava, JCY Wang… - Nature …, 2007 - nature.com
K Takenaka, TK Prasolava, JCY Wang, SM Mortin-Toth, S Khalouei, OI Gan, JE Dick
Nature immunology, 2007nature.com
Graft failure in the transplantation of hematopoietic stem cells occurs despite donor-host
genetic identity of human leukocyte antigens, suggesting that additional factors modulate
engraftment. With the nobese diabetic (NOD)–severe combined immunodeficiency (SCID)
xenotransplantation model, we found that the NOD background allowed better
hematopoietic engraftment than did other strains with equivalent immunodeficiency-related
mutations. We used positional genetics to characterize the molecular basis for this strain …
Abstract
Graft failure in the transplantation of hematopoietic stem cells occurs despite donor-host genetic identity of human leukocyte antigens, suggesting that additional factors modulate engraftment. With the nobese diabetic (NOD)–severe combined immunodeficiency (SCID) xenotransplantation model, we found that the NOD background allowed better hematopoietic engraftment than did other strains with equivalent immunodeficiency-related mutations. We used positional genetics to characterize the molecular basis for this strain specificity and found that the NOD Sirpa allele conferred support for human hematopoiesis. NOD SIRP-α showed enhanced binding to the human CD47 ligand, and its expression on mouse macrophages was required for support of human hematopoiesis. Thus, we have identified Sirpa polymorphism as a potent genetic determinant of the engraftment of human hematopoietic stem cells.
nature.com